Author

A. Al-Kali

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5020828522

Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients

2011 · A. Al-Kali, S. Konoplev, et al. · Haematologica · 17

Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES

2023 · M. Savona, J. Mccloskey, et al. · Leukemia Research

Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: RANDOMIZED PHASE 2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS: INTERIM SAFETY ANALYSIS

2023 · G. Garcia-Manero, K. Bachiashvili, et al. · Leukemia Research

Topic: AS08-Treatment/AS08b-Current treatment options – Lower risk MDS: PHASE 1 STUDY EVALUATING LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS

2023 · G. Garcia-Manero, K. Bachiashvili, et al. · Leukemia Research

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: SOMATIC TP53 SINGLE NUCLEOTIDE VARIANTS, INDELS AND COPY NUMBER ALTERATIONS IN CHRONIC MYELOMONOCYTIC LEUKEMIA (CMML)

2023 · M. Gurney, A. Mangaonkar, et al. · Leukemia Research

P775: Clinical Outcomes and Socioeconomic Factors in Chronic Myelomonocytic Leukemia in the United States Using the National Cancer Database: 2004-2017

2022 · N. Mclaughlin, G. Ruan, et al. · HemaSphere

Works count: 6

Citation count: 17

H-index: 1

I10-index: 1